• FirefoxInstall the new Firefox »
  •  Dow Down 0.01% Nasdaq Up 0.35%

    Halozyme Therapeutics, Inc. (HALO)

    -NasdaqGS
    13.67 Up 0.36(2.67%) 9:43AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:13.31
    Open:N/A
    Bid:13.02 x 1000
    Ask:13.85 x 5800
    1y Target Est:17.50
    Beta:0.83
    Earnings Date:May 11 - May 15 (Est.)
    Day's Range:13.32 - 13.68
    52wk Range:6.88 - 16.55
    Volume:68,964
    Avg Vol (3m):2,019,060
    Market Cap:1.70B
    P/E (ttm):N/A
    EPS (ttm):-0.56
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    HALOUp 2.67%1.70B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):22.01
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.49
    Quarterly EPS Est (Mar-15) :-0.13
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Halozyme Therapeutics, Inc., a biotechnology company, researches, develops, and commercializes human enzymes. Its human enzymes are used to facilitate the delivery of injected drugs and fluids, enhancing the efficacy and the convenience of other d... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback